FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 268 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $467,000 | -24.3% | 20,820 | +100.0% | 0.05% | -37.8% |
| Q3 2021 | $617,000 | +14.9% | 10,410 | +68.2% | 0.07% | +37.0% |
| Q2 2021 | $537,000 | -17.9% | 6,190 | -21.9% | 0.05% | -27.0% |
| Q1 2021 | $654,000 | +116.6% | 7,927 | -9.9% | 0.07% | +64.4% |
| Q2 2020 | $302,000 | -42.9% | 8,798 | -67.4% | 0.04% | -47.1% |
| Q4 2019 | $529,000 | +192.3% | 27,025 | +161.9% | 0.08% | +183.3% |
| Q1 2019 | $181,000 | +82.8% | 10,317 | -52.4% | 0.03% | +30.4% |
| Q1 2017 | $99,000 | – | 21,654 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |